Immunocore
IMCR
IMCR
104 hedge funds and large institutions have $1.73B invested in Immunocore in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
21% more funds holding
Funds holding: 86 → 104 (+18)
6.47% more ownership
Funds ownership: 60.31% → 66.78% (+6.5%)
Holders
104
Holding in Top 10
8
Calls
$10.3M
Puts
$6.12M
Top Buyers
| 1 | +$84.4M | |
| 2 | +$63.2M | |
| 3 | +$35.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.9M |
| 5 |
BlackRock
New York
|
+$16.5M |
Top Sellers
| 1 | -$52.8M | |
| 2 | -$34.6M | |
| 3 | -$10.4M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.85M |
| 5 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
-$8.92M |